TSCAN THERAPEUTICS INC TCRX
COM · Common Stock · CUSIP 89854M101
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersWaltham, MA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($88.9k this quarter). Holder counts are more reliable. Implied quarter-end price ≈ $2.50.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 27 |
| Q4 2022 | 29 |
| Q1 2023 | 29 |
| Q2 2023 | 29 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 12 | 7 |
| Q1 2023 | 12 | 6 |
| Q2 2023 | 13 | 9 |
Biggest buyers
| Lynx1 Capital Management LP | New | +5.2m |
| EcoR1 Capital, LLC | New | +5.0m |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Added | +3.5m |
| BVF INC/IL | New | +3.0m |
| VANGUARD GROUP INC | Added | +1.1m |
| Simplify Asset Management Inc. | Added | +500.0k |
| Monashee Investment Management LLC | New | +400.0k |
| RENAISSANCE TECHNOLOGIES LLC | Added | +135.9k |
| STIFEL FINANCIAL CORP | New | +99.0k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +16.4k |
Biggest sellers
| BlackRock Inc. | Reduced | -251.6k |
| Newtyn Management, LLC | Sold out | -236.8k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | Reduced | -65.0k |
| MORGAN STANLEY | Reduced | -22.8k |
| CANNELL CAPITAL LLC | Sold out | -14.7k |
| LPL Financial LLC | Sold out | -12.0k |
| Tower Research Capital LLC (TRC) | Sold out | -4.1k |
| UBS Group AG | Reduced | -2.1k |
| OSAIC HOLDINGS, INC. | Sold out | -1 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Lynx1 Capital Management LP 13G · passive investor -1.9 pts · filed 2026-08-14 | 13.1% |
| BIOTECHNOLOGY VALUE FUND L P 13G · passive investor no change · filed 2026-08-14 | 10.0% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 13G · institution filed 2025-02-12 | 7.1% |
| K2 HealthVentures Equity Trust LLC 13G · passive investor filed 2025-02-14 | 6.9% |
| Readout Capital, LP 13G · passive investor new · filed 2026-09-25 | 5.4% |
Insider purchases and sales in Q2 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2021 | 0 | — | 0 | — | — |
| Q4 2021 | 0 | — | 0 | — | — |
| Q1 2022 | 1 | $51.0k | 0 | — | — |
| Q2 2022 | 2 | $2.6m | 0 | — | — |
| Q3 2022 | 0 | — | 0 | — | — |
| Q4 2022 | 1 | $9.2k | 0 | — | — |
| Q1 2023 | 0 | — | 0 | — | — |
| Q2 2023 | 1 | $99.6k | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2023-06-02 | BARBERICH TIMOTHY J Director | Bought | $99.6k37.9k shares |
| 2023-05-31 | Nichols Weston +1 10% owner · See footnote | Sold | $63.9k25.4k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| Lynx1 Capital Management LP 8.56% of their portfolio | 5.2m $13.1m | New |
| EcoR1 Capital, LLC 0.33% of their portfolio | 5.0m $12.5m | New |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.02% of their portfolio | 4.0m $10.0m | Added +3.5m |
| BVF INC/IL 0.21% of their portfolio | 3.0m $7.5m | New |
| BAKER BROS. ADVISORS LP 0.04% of their portfolio | 2.8m $7.0m | Unchanged |
| VANGUARD GROUP INC 0.00% of their portfolio | 1.4m $3.4m | Added +1.1m |
| BlackRock Inc. 0.00% of their portfolio | 1.3m $3.2m | Reduced -251.6k |
| Deer Management Co. LLC 0.28% of their portfolio | 1.2m $3.1m | Unchanged |
| Alphabet Inc. 0.14% of their portfolio | 1.1m $2.7m | Unchanged |
| Simplify Asset Management Inc. 0.47% of their portfolio | 1.0m $2.6m | Added +500.0k |
| DC Funds, LP 33.55% of their portfolio | 630.0k $1.6m | Unchanged |
| Monashee Investment Management LLC 0.24% of their portfolio | 400.0k $1.0m | New |
| Tekla Capital Management LLC 0.02% of their portfolio | 200.0k $500.0k | Unchanged |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 147.5k $369.0k | Added +135.9k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 116.9k $292.2k | Added +16.4k |
| MORGAN STANLEY 0.00% of their portfolio | 108.5k $271.2k | Reduced -22.8k |
| STIFEL FINANCIAL CORP 0.00% of their portfolio | 99.0k $247.5k | New |
| NewEdge Wealth, LLC 0.01% of their portfolio | 91.5k $228.7k | Unchanged |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 50.0k $125.0k | Reduced -65.0k |
| STATE STREET CORP 0.00% of their portfolio | 38.5k $96.2k | Added +14.5k |
| DC Investments Management, LLC 0.10% of their portfolio | 35.6k $88.9k | Unchanged |
| Privium Fund Management (UK) Ltd 0.03% of their portfolio | 15.8k $40.0k | Unchanged |
| NORTHERN TRUST CORP 0.00% of their portfolio | 15.1k $37.6k | Added +905 |
| Waldron Private Wealth LLC 0.00% of their portfolio | 10.0k $25.0k | Unchanged |
| UBS Group AG 0.00% of their portfolio | 1.1k $2.8k | Reduced -2.1k |
| ATLAS CAPITAL ADVISORS INC. 0.00% of their portfolio | 896 $2.2k | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 200 $500 | Unchanged |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 80 $200 | Added +5 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |